4//SEC Filing
Lecault Veronique 4
Accession 0001209191-22-059573
CIK 0001703057other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 12:28 PM ET
Size
5.5 KB
Accession
0001209191-22-059573
Insider Transaction Report
Form 4
Lecault Veronique
DirectorChief Technology Officer
Transactions
- Award
Share Options (right to buy)
2022-12-01+462,535→ 3,392,689 totalExercise: $13.18Exp: 2032-12-01→ Common Shares (462,535 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834418
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 12:28 PM ET
- Size
- 5.5 KB